[Asia Economy Reporter Kang Nahum] MetaLabs announced on the 25th that its subsidiary MetaCare will acquire 13,508 shares of medical consulting firm Liting Labs for approximately 6.5 billion KRW.


After the stock acquisition, MetaCare's stake in Liting Labs will be 9.6%. The scheduled date for the stock acquisition is the 26th.



MetaLabs stated that the purpose of this stock acquisition is to "secure growth momentum for the healthcare platform through business expansion."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing